Researchers have identified groups of patients with pleural mesothelioma, a rare and aggressive cancer, who are more likely to respond to immunotherapy, offering clues about why only some tumors respond to the treatment.
Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has developed a cloud-based informatics platform that combines clinical and genomic data from multiple sources into one unified platform.
